Lipofabrik Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.79M
Latest Deal Amount
  • Investors
  • 4

Lipofabrik General Information

Description

Developer of biological and biodegradable molecules designed to offer products through bio-processes based on renewable resources. The company's molecules are prepared by doing research on dipeptides that are produced by a bacterial class, enabling clients to get advanced products for feeding animals and for treating diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 917 rue des Saules
  • 59810 Lesquin
  • France
+33 03 00 00 00 00

Lipofabrik Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipofabrik Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Apr-2019 $1.79M 00.000 Completed Generating Revenue
5. Later Stage VC 29-Mar-2018 00.000 00.000 00.00 Completed Startup
4. Grant 15-Dec-2017 000.00 00.00 Completed Startup
3. Early Stage VC 03-Jun-2015 00000 00.00 00.000 Completed Startup
2. Angel (individual) 19-Dec-2013 $641K $641K 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Lipofabrik’s complete valuation and funding history, request access »

Lipofabrik Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference 0,000 0000.000000 00000.00 00000.00 00 00000.00 00.000
Preference 000 0000.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 376 $12.328399 $1541.05 $1541.05 1x $1541.05 8.48%
To view Lipofabrik’s complete cap table history, request access »

Lipofabrik Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biological and biodegradable molecules designed to offer products through bio-processes based on renewable
Drug Discovery
Lesquin, France
12 As of 2021
00.000
0000000000 00.000

000 0000

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000

00 00000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000000
Durham, NC
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lipofabrik Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
00000000 Venture Capital-Backed New York, NY 00 0000 00000000000 0000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 0000 000000000000 0000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
You’re viewing 5 of 5 competitors. Get the full list »

Lipofabrik Patents

Lipofabrik Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017385886-A1 Biostimulant composition for plant growth, containing lipopeptides Pending 30-Dec-2016 000000000
ES-2790879-T3 Biostimulant composition for plant growth containing lipopeptides Active 30-Dec-2016 000000000
FR-3061410-B1 Biostimulant composition of plant growth obtained from surnantant of bacillus strain culture sp. Active 30-Dec-2016 000000000
CA-3048327-A1 Biostimulant composition for plant growth, containing lipopeptides Pending 30-Dec-2016 000000000
FR-3061410-A1 Biostimulant composition of plant growth obtained from bacillus sp. Granted 30-Dec-2016 A01N63/50

Lipofabrik Executive Team (3)

Name Title Board Seat Contact Info
Arnaud Delecroix Chief Executive Officer, President & Publication Director
François Coutte Co-Founder, Partner & Scientific Advisor
Philippe Jacques Co-Founder, Partner, Scientific Advisor & Researcher
To view Lipofabrik’s complete executive team members history, request access »

Lipofabrik Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipofabrik Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Nord France Amorçage Venture Capital Minority 000 0000 000000 0
Siparex Group PE/Buyout Minority 000 0000 000000 0
Eurasanté Bio Incubator Accelerator/Incubator 000 0000 000000 0
To view Lipofabrik’s complete investors history, request access »